Infectious Disease Companies Discussed in Wall Street Transcript Biotechnology Report (Wall...

67 WALL STREET, New York - June 27, 2008 - The Wall Street Transcript has just published its Biotechnology issue, a report offering a timely review of the sector to serious investors and industry executives. This 81-page feature contains a roundtable forum and industry commentary through in depth interviews with CEOs from 13 firms and 2 analysts. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online Topics covered: FDA approval process, Failures in oncology trials, Safety concerns, Public and private funding, PIPES and structured financing, Big Pharma partnerships, Development stage companies, Late-stage product companies, Technology platform companies, Outsourcing trends & CRO, Outlook for oncology companies, Urology companies and latest developments, Stock Picks, Stocks to Avoid.... [read full story]